Thora Bjorg joined Coripharma as Director R&D in 2019.

After serving as Executive Director of Clinical R&D EU & RoW at Actavis since 2007, Thora Bjorg was appointed Head of R&D Iceland in 2015. She was formerly CEO of Lyfjaþróun, a nasal drug delivery company, until its acquisition by Actavis in 2007.